Selskabets formål er at drive konsulentvirksomhed, investeringsvirksomhed og forskning samt hermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 4 mio. | 10.6 mio. | 92.7 mio. | -9 mio. | 1 | |
CVR: 21142743
Secondary names: CCBR A/S
Compared to 992 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
The financial health of Center for Clinical and Basic Research A/S appears to be concerning, with a significant decline in revenue from 120.6 million DKK in 2020 to just 3.98 million DKK in 2024, indicating a troubling downward trend. Despite a profit of 10.63 million DKK in 2024, the company has consistently reported negative equity, which stood at -8.96 million DKK in 2024, reflecting ongoing financial instability. The fluctuating profit margins, including a notable loss of 23.76 million DKK in 2021, raise concerns about operational efficiency and sustainability. Overall, the company faces challenges in maintaining its position within the research and experimental development sector, particularly given its declining revenue trajectory and negative equity.
AI-generated summary
Companies in the same industry and area
CVR 45796256
CVR 18631776
CVR 39955490
CVR 44742438
CVR 10021065
companydata.dk